Evidence map›Paper›PMID 33445741›Full record

ArticleCancers2021

Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma-A Retrospective Analysis of a Swedish Cohort.

Hannah Björn Andtback, Viveca Björnhagen-Säfwenberg, Hao Shi, Weng-Onn Lui, Giuseppe V Masucci, Lisa Villabona

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Sex-related differences in the efficacy and toxicity of cancer treatments.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Merkel Cell Carcinoma With Isolated Pancreatic Metastasis.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hannah Björn AndtbackDepartment Oncology-Pathology, Karolinska Institute and BioClinicum, Karolinska University Hospital, 17176 Stockholm, Sweden.
Viveca Björnhagen-SäfwenbergDepartment of Reconstructive Plastic Surgery, Karolinska University Hospital, 17176 Stockholm, Sweden.
Hao ShiDepartment Oncology-Pathology, Karolinska Institute and BioClinicum, Karolinska University Hospital, 17176 Stockholm, Sweden.
Weng-Onn LuiDepartment Oncology-Pathology, Karolinska Institute and BioClinicum, Karolinska University Hospital, 17176 Stockholm, Sweden.ORCID 0000-0003-4717-4473
Giuseppe V MasucciDepartment Oncology-Pathology, Karolinska Institute and BioClinicum, Karolinska University Hospital, 17176 Stockholm, Sweden.ORCID 0000-0002-9583-2306
Lisa VillabonaDepartment Oncology-Pathology, Karolinska Institute and BioClinicum, Karolinska University Hospital, 17176 Stockholm, Sweden.
Karolinska University Hospital · SE

Funding

Radiumhemmets Forskningsfonder 184043
6 · The paper itself

Abstract

Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer where Merkel cell Polyomavirus (MCPyV) contributes to the pathogenesis. In an adjuvant setting, radiotherapy (RT) is believed to give a survival benefit. The prognostic impact of sex related to MCPyV-status and adjuvant RT were analyzed in patients referred to Karolinska University Hospital. Data were collected from 113 patients' hospital records and MCPyV analyses were made in 54 patients (48%). We found a significantly better overall survival (OS) for women compared to men and a significant difference in OS in patients receiving adjuvant RT. Furthermore, we found that men with virus negative MCC have an increased risk for earlier death (HR 3.6). This indicates that MCPyV positive and negative MCC act as two different diseases, and it might be due to different mechanism in the immune response between male and female patients. This could have significance in tailoring treatment and follow-up in MCC patients in the future.

Indexed as

merkel cell carcinomamerkel cell polyoma virusradiotherapysex

Identifiers

PMID33445741
PMCPMC7828197
OpenAlexW3121844790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.